1. 2643 Neoadjuvant sorafenib, gemcitabine, and cisplatin (SGC) for muscle-invasive urothelial bladder cancer (UBC): Updated clinical and translational findings of an open-label, single group, phase 2 study. (September 2015) Authors: Necchi, A.; Giannatempo, P.; Mariani, L.; Raggi, D.; Nicolai, N.; Piva, L.; Biasoni, D.; Catanzaro, M.; Torelli, T.; Stagni, S.; Calareso, G.; Togliardi, E.; Colecchia, M.; Busico, A.; Perrone, F.; Pelosi, G.; Maffezzini, M.; Salvioni, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-1827 M1 microglia polarization induced by radiotherapy and dendritic cell immunotherapy combination. (May 2022) Authors: Pinzi, V.; Di Ianni, N.; Fumagalli, M.L.; Maffezzini, M.; Fariselli, L.; Pellegatta, S. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Estimates of prostate cancer burden in Italy. (February 2016) Authors: Capocaccia, R.; Foschi, R.; Zucchetto, A.; Valdagni, R.; Nicolai, N.; Maffezzini, M.; Gatta, G. Journal: Cancer epidemiology Issue: Volume 40(2016:Feb.) Page Start: 166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗